The role of plasminogen activators in the development of atherosclerotic and restenotic lesions
- 1 June 1996
- journal article
- Published by Elsevier in Fibrinolysis
- Vol. 10, 33-35
- https://doi.org/10.1016/s0268-9499(96)80043-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Plasminogen Activator Expression in Human Atherosclerotic LesionsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Expression of LDL receptor-related protein/alpha 2-macroglobulin receptor in human normal and atherosclerotic arteries.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1994
- Physiological consequences of loss of plasminogen activator gene function in miceNature, 1994
- Role of endogenous platelet-derived growth factor in arterial smooth muscle cell migration after balloon catheter injury.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- Localization and production of plasminogen activator inhibitor-1 in human healthy and atherosclerotic arteries.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Prelesional Modifications of the Vessel Wall in Hyperlipidemic Atherogenesis.Annals of the New York Academy of Sciences, 1990
- Release of basic fibroblast growth factor-heparan sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity.The Journal of cell biology, 1990
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987